BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21163704)

  • 41. Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases.
    Boxberger N; Hecker M; Zettl UK
    J Immunol; 2019 Apr; 202(8):2177-2187. PubMed ID: 30962309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.
    Van Gorp H; Van Opdenbosch N; Lamkanfi M
    Cold Spring Harb Perspect Biol; 2019 Jan; 11(1):. PubMed ID: 29038114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases.
    Ter Haar NM; Jansen MHA; Frenkel JF; Vastert SJ
    Clin Immunol; 2020 Oct; 219():108538. PubMed ID: 32681980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.
    de Torre-Minguela C; Mesa Del Castillo P; Pelegrín P
    Front Immunol; 2017; 8():43. PubMed ID: 28191008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammasomes: guardians of cytosolic sanctity.
    Lamkanfi M; Dixit VM
    Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inflammasomes in human diseases].
    Jamilloux Y; Sève P; Henry T
    Rev Med Interne; 2014 Nov; 35(11):730-41. PubMed ID: 24907108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
    Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
    Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice.
    Yu CH; Moecking J; Geyer M; Masters SL
    J Mol Biol; 2018 Jan; 430(2):142-152. PubMed ID: 28733143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammasomes and its importance in viral infections.
    Shrivastava G; León-Juárez M; García-Cordero J; Meza-Sánchez DE; Cedillo-Barrón L
    Immunol Res; 2016 Dec; 64(5-6):1101-1117. PubMed ID: 27699580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential roles of inflammasomes in the pathophysiology of Psoriasis: A comprehensive review.
    Shahi A; Afzali S; Amirzargar A; Mohaghegh P; Salehi S; Mansoori Y
    Mol Immunol; 2023 Sep; 161():44-60. PubMed ID: 37481828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis.
    Deswaerte V; Ruwanpura SM; Jenkins BJ
    Mol Immunol; 2017 Jun; 86():3-9. PubMed ID: 27697299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NLRs, inflammasomes, and viral infection.
    Jacobs SR; Damania B
    J Leukoc Biol; 2012 Sep; 92(3):469-77. PubMed ID: 22581934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of NLRP3 Inflammasome in Pneumococcal Infections.
    Surabhi S; Cuypers F; Hammerschmidt S; Siemens N
    Front Immunol; 2020; 11():614801. PubMed ID: 33424869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.
    Deuteraiou K; Kitas G; Garyfallos A; Dimitroulas T
    Rheumatol Int; 2018 Aug; 38(8):1345-1354. PubMed ID: 29869008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies.
    Ferreira I; Liberal J; Martins JD; Silva A; Neves BM; Cruz MT
    Curr Drug Targets; 2017; 18(9):1003-1018. PubMed ID: 27660056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells.
    Chu JQ; Gao FF; Wu W; Li C; Pan Z; Sun J; Wang H; Huang C; Lee SH; Quan JH; Lee YH
    Parasit Vectors; 2021 Mar; 14(1):153. PubMed ID: 33712075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of inflammasome activation.
    Man SM; Kanneganti TD
    Immunol Rev; 2015 May; 265(1):6-21. PubMed ID: 25879280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensing damage by the NLRP3 inflammasome.
    Leemans JC; Cassel SL; Sutterwala FS
    Immunol Rev; 2011 Sep; 243(1):152-62. PubMed ID: 21884174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms and functions of inflammasomes.
    Lamkanfi M; Dixit VM
    Cell; 2014 May; 157(5):1013-22. PubMed ID: 24855941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.